T-Cell Immunotherapy Market Report

China T-Cell Immunotherapy Industry Market Research Report 2023-2029

  • POSTDATE：Aug 27, 2023
  • PAGES：167
  • REPORT CODE：GMM1762488
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the T-Cell Immunotherapy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Altor Bioscience Corporation

    • Kite Pharma

    • Takara Bio

    • Novartis

    • Unum Therapeutics

    • Cellectis

    • Adaptimmune

    By Type:

    • TCR

    • CAR-T

    • TIL Therapies

    By Application:

    • Esophagus Cancer

    • Pancreatic Cancer

    • Colorectal Cancer

    • Lung Cancer

    • Others

    • Stomach Cancer

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China T-Cell Immunotherapy Market Overview 2018-2029

    • 1.1 China T-Cell Immunotherapy Industry Development Overview

    • 1.2 China T-Cell Immunotherapy Industry Development History

    • 1.3 China T-Cell Immunotherapy Industry Market Size (2018-2029)

    • 1.4 China T-Cell Immunotherapy Market Analysis by Type from Production Side

      • 1.4.1 China T-Cell Immunotherapy Production Volume, Production Value and Growth Rate of TCR (2018-2029)

      • 1.4.2 China T-Cell Immunotherapy Production Volume, Production Value and Growth Rate of CAR-T (2018-2029)

      • 1.4.3 China T-Cell Immunotherapy Production Volume, Production Value and Growth Rate of TIL Therapies (2018-2029)

    • 1.5 China T-Cell Immunotherapy Market Analysis by Application from Consumption End

      • 1.5.1 China T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Esophagus Cancer (2018-2029)

      • 1.5.2 China T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Pancreatic Cancer (2018-2029)

      • 1.5.3 China T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Colorectal Cancer (2018-2029)

      • 1.5.4 China T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

      • 1.5.5 China T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.6 China T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Stomach Cancer (2018-2029)

    • 1.6 China T-Cell Immunotherapy Market Analysis by Region

      • 1.6.1 North China T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    Chapter 2 China T-Cell Immunotherapy Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on T-Cell Immunotherapy Market Status and Competition at home and abroad in 2023

      • 2.2.2 China T-Cell Immunotherapy Market Status and Competition Analysis in 2023

      • 2.2.3 China T-Cell Immunotherapy Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China T-Cell Immunotherapy Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on T-Cell Immunotherapy Industry Development

    Chapter 3 T-Cell ImmunotherapyIndustry Chain Analysis

    • 3.1 T-Cell Immunotherapy Industry Chain

    • 3.2 T-Cell Immunotherapy Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the T-Cell Immunotherapy Market

    • 3.3 T-Cell Immunotherapy Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the T-Cell Immunotherapy Market

    Chapter 4 China T-Cell Immunotherapy Market, by Type

    • 4.1 China T-Cell Immunotherapy Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China T-Cell Immunotherapy Total Production Volume and Growth Rate from Production Side

    • 4.5 China T-Cell Immunotherapy Production Volume and Growth Rate, by Type

      • 4.5.1 China T-Cell Immunotherapy Production Volume and Growth Rate of TCR

      • 4.5.2 China T-Cell Immunotherapy Production Volume and Growth Rate of CAR-T

      • 4.5.3 China T-Cell Immunotherapy Production Volume and Growth Rate of TIL Therapies

    Chapter 5 China T-Cell Immunotherapy Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China T-Cell Immunotherapy Total Market Size and Growth Rate from Consumption End

    • 5.5 China T-Cell Immunotherapy Market Size and Growth Rate, by Application

      • 5.5.1 China T-Cell Immunotherapy Market Size and Growth Rate of Esophagus Cancer

      • 5.5.2 China T-Cell Immunotherapy Market Size and Growth Rate of Pancreatic Cancer

      • 5.5.3 China T-Cell Immunotherapy Market Size and Growth Rate of Colorectal Cancer

      • 5.5.4 China T-Cell Immunotherapy Market Size and Growth Rate of Lung Cancer

      • 5.5.5 China T-Cell Immunotherapy Market Size and Growth Rate of Others

      • 5.5.6 China T-Cell Immunotherapy Market Size and Growth Rate of Stomach Cancer

    Chapter 6 China T-Cell Immunotherapy Market, by Region

    • 6.1 China T-Cell Immunotherapy Production Volume and Production Value, by Region

    • 6.2 China T-Cell Immunotherapy Sales Volume and Sales Value, by Region

    Chapter 7 North China T-Cell Immunotherapy Market Analysis

    • 7.1 North China T-Cell Immunotherapy Market, by Type

    • 7.2 North China T-Cell Immunotherapy Market, by Application

    Chapter 8 Central China T-Cell Immunotherapy Market Analysis

    • 8.1 Central China T-Cell Immunotherapy Market, by Type

    • 8.2 Central China T-Cell Immunotherapy Market, by Application

    Chapter 9 South China T-Cell Immunotherapy Market Analysis

    • 9.1 South China T-Cell Immunotherapy Market, by Type

    • 9.2 South China T-Cell Immunotherapy Market, by Application

    Chapter 10 East China T-Cell Immunotherapy Market Analysis

    • 10.1 East China T-Cell Immunotherapy Market, by Type

    • 10.2 East China T-Cell Immunotherapy Market, by Application

    Chapter 11 Northeast China T-Cell Immunotherapy Market Analysis

    • 11.1 Northeast China T-Cell Immunotherapy Market, by Type

    • 11.2 Northeast China T-Cell Immunotherapy Market, by Application

    Chapter 12 Southwest China T-Cell Immunotherapy Market Analysis

    • 12.1 Southwest China T-Cell Immunotherapy Market, by Type

    • 12.2 Southwest China T-Cell Immunotherapy Market, by Application

    Chapter 13 Northwest China T-Cell Immunotherapy Market Analysis

    • 13.1 Northwest China T-Cell Immunotherapy Market, by Type

    • 13.2 Northwest China T-Cell Immunotherapy Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Altor Bioscience Corporation

        • 14.1.1 Altor Bioscience Corporation Company Profile

        • 14.1.2 Altor Bioscience Corporation T-Cell Immunotherapy Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Kite Pharma

        • 14.2.1 Kite Pharma Company Profile

        • 14.2.2 Kite Pharma T-Cell Immunotherapy Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Takara Bio

        • 14.3.1 Takara Bio Company Profile

        • 14.3.2 Takara Bio T-Cell Immunotherapy Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Novartis

        • 14.4.1 Novartis Company Profile

        • 14.4.2 Novartis T-Cell Immunotherapy Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Unum Therapeutics

        • 14.5.1 Unum Therapeutics Company Profile

        • 14.5.2 Unum Therapeutics T-Cell Immunotherapy Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Cellectis

        • 14.6.1 Cellectis Company Profile

        • 14.6.2 Cellectis T-Cell Immunotherapy Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Adaptimmune

        • 14.7.1 Adaptimmune Company Profile

        • 14.7.2 Adaptimmune T-Cell Immunotherapy Market Performance

        • 14.7.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 T-Cell Immunotherapy Industry Research Conclusions

    • 15.2 T-Cell Immunotherapy Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China T-Cell Immunotherapy Industry Market Size (2018-2029)

    • Figure China T-Cell Immunotherapy Production Volume, Production Value and Growth Rate of TCR (2018-2029)

    • Figure China T-Cell Immunotherapy Production Volume, Production Value and Growth Rate of CAR-T (2018-2029)

    • Figure China T-Cell Immunotherapy Production Volume, Production Value and Growth Rate of TIL Therapies (2018-2029)

    • Figure China T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Esophagus Cancer (2018-2029)

    • Figure China T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Pancreatic Cancer (2018-2029)

    • Figure China T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Colorectal Cancer (2018-2029)

    • Figure China T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

    • Figure China T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Stomach Cancer (2018-2029)

    • Figure North China T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Central China T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure South China T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure East China T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Northeast China T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Southwest China T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Northwest China T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure T-Cell Immunotherapy Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China T-Cell Immunotherapy Market Share by Type in 2018

    • Figure China T-Cell Immunotherapy Market Share by Type in 2023

    • Figure China T-Cell Immunotherapy Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China T-Cell Immunotherapy Production Volume and Growth Rate of TCR (2018-2023)

    • Figure China T-Cell Immunotherapy Production Volume and Growth Rate of CAR-T (2018-2023)

    • Figure China T-Cell Immunotherapy Production Volume and Growth Rate of TIL Therapies (2018-2023)

    • Figure China T-Cell Immunotherapy Market Share by Application in 2018

    • Figure China T-Cell Immunotherapy Market Share by Application in 2023

    • Figure China T-Cell Immunotherapy Total Market Size and Growth Rate from Consumption End

    • Figure China T-Cell Immunotherapy Market Size and Growth Rate of Esophagus Cancer (2018-2023)

    • Figure China T-Cell Immunotherapy Market Size and Growth Rate of Pancreatic Cancer (2018-2023)

    • Figure China T-Cell Immunotherapy Market Size and Growth Rate of Colorectal Cancer (2018-2023)

    • Figure China T-Cell Immunotherapy Market Size and Growth Rate of Lung Cancer (2018-2023)

    • Figure China T-Cell Immunotherapy Market Size and Growth Rate of Others (2018-2023)

    • Figure China T-Cell Immunotherapy Market Size and Growth Rate of Stomach Cancer (2018-2023)

    • Table China T-Cell Immunotherapy Production Volume by Region (2018-2023)

    • Table China T-Cell Immunotherapy Production Volume Share by Region (2018-2023)

    • Figure China T-Cell Immunotherapy Production Volume Share by Region (2018-2023)

    • Table China T-Cell Immunotherapy Production Value by Region (2018-2023)

    • Table China T-Cell Immunotherapy Production Value Share by Region (2018-2023)

    • Figure China T-Cell Immunotherapy Production Value Share by Region (2018-2023)

    • Table China T-Cell Immunotherapy Sales Volume by Region (2018-2023)

    • Table China T-Cell Immunotherapy Sales Volume Share by Region (2018-2023)

    • Figure China T-Cell Immunotherapy Sales Volume Share by Region (2018-2023)

    • Table China T-Cell Immunotherapy Sales Value by Region (2018-2023)

    • Table China T-Cell Immunotherapy Sales Value Share by Region (2018-2023)

    • Figure China T-Cell Immunotherapy Sales Value Share by Region (2018-2023)

    • Table North China T-Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table North China T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure North China T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table North China T-Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table North China T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure North China T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Central China T-Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table Central China T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure Central China T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table Central China T-Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table Central China T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure Central China T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table South China T-Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table South China T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure South China T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table South China T-Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table South China T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure South China T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table East China T-Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table East China T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure East China T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table East China T-Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table East China T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure East China T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Northeast China T-Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table Northeast China T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure Northeast China T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table Northeast China T-Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table Northeast China T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure Northeast China T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Southwest China T-Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table Southwest China T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure Southwest China T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table Southwest China T-Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table Southwest China T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure Southwest China T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Northwest China T-Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table Northwest China T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure Northwest China T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table Northwest China T-Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table Northwest China T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure Northwest China T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Altor Bioscience Corporation Company Profile

    • Table Altor Bioscience Corporation T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Kite Pharma Company Profile

    • Table Kite Pharma T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Takara Bio Company Profile

    • Table Takara Bio T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Unum Therapeutics Company Profile

    • Table Unum Therapeutics T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Cellectis Company Profile

    • Table Cellectis T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Adaptimmune Company Profile

    • Table Adaptimmune T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US